AprilBio financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

에이프릴바이오KRX:397030 · KOSDAQ · Healthcare

₩16,960-20.38%

2026-10-02 close

AprilBio's published financial data is dated 2026-10-04. 2024 revenue was KRW 27.51B. 2024 operating profit was KRW 16.75B.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy